Company Details
  • Taizhou Volsen Chemical Co., Ltd.

  •  [Zhejiang,China]
  • Business Type:Manufacturer
  • Main Mark: Americas , Asia , East Europe , Europe , North Europe , Other Markets , West Europe , Worldwide
  • Exporter:91% - 100%
  • Certs:GS, CE, ISO9001, ISO14000
  • Description:ALK/EGFR Inhibitor 1197953-54-0,Non-small Cell Lung Cancer Treatment CAS 1197953-54-0,CAS Number 1197953-54-0
Taizhou Volsen Chemical Co., Ltd. ALK/EGFR Inhibitor 1197953-54-0,Non-small Cell Lung Cancer Treatment CAS 1197953-54-0,CAS Number 1197953-54-0
Home > Products > Pharmaceutical Intermediates > Anti-Tumor/Cancer > AP26113;AP-26113 (Brigatinib) CAS 1197953-54-0

AP26113;AP-26113 (Brigatinib) CAS 1197953-54-0

Share to:  
    Unit Price: USD 1 / Kilogram
    Payment Type: T/T
    Incoterm: CIF
    Min. Order: 1 Kilogram
    Delivery Time: 15 Days

Basic Info

Model No.: 1197953-54-0

Additional Info

Packaging: AS REQUIRED

Productivity: KGS

Brand: VOLSENCHEM

Transportation: Air

Place of Origin: CHINA

Supply Ability: TRUE MANUFACTURER

Product Description

Brigatinib CAS number 1197953-54-0 referred to as AP26113, it is an inhibitor of lung cancer ALK target, is a non-small cell lung cancer targeted drugs. AP26113 is generally used after Crizotinib resistance, so in 2014 year the FDA awarded its tyrosine kinase inhibitor drug AP26113 orphan drug qualification for the treatment of methotrexate-resistant anaplastic lymphoma kinase Positive (ALK +) metastatic non-small cell lung cancer (NSCLC) patients. It has been shown that AP26113 inhibits at least 10 times more potency and selectivity than ALK bikazolidine , and that AP26113 is also effective for brain metastases in lung cancer.
Lung cancer ALK target is actually a small market, because the probability of lung cancer ALK mutation is not high, but crizotinib in this area is ALK inhibitor currently the only one listed , the effect is also very good, AP26113 CAS number 1197953-54-0 is the second Models, can be considered the second generation of ALK inhibitors, AP26113 is expected to break the monopoly position of crizotinib.
Thera. Category: Anti-cancer

Cas No.:1197953-54-0

Synonyms:5-Chloro-N4-[2-(dimethylphosphinyl)phenyl]-N2-[2-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-2,4-pyrimidinediamine;Brigatinib;AP26113 (Brigatinib);Brigatinib, AP26113;

AP26113

Molecular Formula:C29H39ClN7O2P

Molecular Weight: 584.10176

Purity: ≥98%

Packing: Export worthy packing

Material Safety Data Sheet: Available on request

AP26113/brigatinib

1197953-54-0

2,5-dichloro-N-(2-(dimethylphosphoryl)phenyl)pyrimidin-4-amine

1197953-49-3

2-(diMethylphosphoryl)aniline

1197953-47-1

2-Methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]aniline

761440-75-9

Looking for ideal ALK/EGFR Inhibitor 1197953-54-0 Manufacturer & supplier ? We have a wide selection at great prices to help you get creative. All the Non-small Cell Lung Cancer Treatment CAS 1197953-54-0 are quality guaranteed. We are China Origin Factory of CAS Number 1197953-54-0. If you have any question, please feel free to contact us.

Product Categories : Pharmaceutical Intermediates > Anti-Tumor/Cancer

Product Images
  • AP26113;AP-26113 (Brigatinib) CAS 1197953-54-0
Email to this supplier
  • *Subject:
  • *Messages:
    Your message must be between 20-8000 characters
Copyright © 2018 Taizhou Volsen Chemical Co., Ltd. All rights reserved.
Communicate with Supplier?Supplier
Amy Cheng Ms. Amy Cheng
What can I do for you?